What is Neonatal Abstinence Syndrome?

Neonatal Abstinence Syndrome (NAS) is primarily associated with withdrawal symptoms in newborns who have been exposed to certain substances, such as opioids, during pregnancy. When a pregnant individual uses these substances, the fetus becomes dependent on them. Upon birth, the infant is no longer receiving these substances and begins to experience withdrawal symptoms. This condition is characterized by several symptoms, including irritability, feeding difficulties, tremors, and seizures, among others.

This understanding of NAS emphasizes the importance of recognizing the impact of maternal substance use on fetal development and highlights the need for appropriate medical interventions and support for affected newborns and their families. The other options do not accurately capture the essence of NAS, as they pertain to different medical conditions or scenarios unrelated to the withdrawal of drugs in newborns.